These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36354044)

  • 1. Oral insulin delivery: a patent review.
    Sharma S; Mittal A; Mehra A
    Pharm Pat Anal; 2022 Nov; 11(6):199-212. PubMed ID: 36354044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent patents on oral insulin delivery.
    Navgire SD; Satpute AS; Pandey S; Patil AT
    Recent Pat Drug Deliv Formul; 2014; 8(3):202-5. PubMed ID: 24981288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Progress of Chitosan and Chitosan Derivatives-Based Nanoparticles: Pharmaceutical Perspectives of Oral Insulin Delivery.
    Seyam S; Nordin NA; Alfatama M
    Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33066443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral insulin delivery systems using chitosan-based formulation: a review.
    Al Rubeaan K; Rafiullah M; Jayavanth S
    Expert Opin Drug Deliv; 2016; 13(2):223-37. PubMed ID: 26549528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances of polysaccharide-based nanoparticles for oral insulin delivery.
    Hu Q; Luo Y
    Int J Biol Macromol; 2018 Dec; 120(Pt A):775-782. PubMed ID: 30170057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Net-Neutral Nanoparticles-Extruded Microcapsules for Oral Delivery of Insulin.
    Lu X; Li J; Xue M; Wang M; Guo R; Wang B; Zhang H
    ACS Appl Mater Interfaces; 2023 Jul; 15(28):33491-33503. PubMed ID: 37405815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
    Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
    ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles.
    Dyer AM; Hinchcliffe M; Watts P; Castile J; Jabbal-Gill I; Nankervis R; Smith A; Illum L
    Pharm Res; 2002 Jul; 19(7):998-1008. PubMed ID: 12180553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-sodium lauryl sulfate nanoparticles as a carrier system for the in vivo delivery of oral insulin.
    Elsayed A; Al-Remawi M; Qinna N; Farouk A; Al-Sou'od KA; Badwan AA
    AAPS PharmSciTech; 2011 Sep; 12(3):958-64. PubMed ID: 21761276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eudragit L-100 Capsules Aromatize and Quaternerize Chitosan for Insulin Nanoparticle Oral Delivery During Toxic Oxidative Stress in Rat Liver and Kidney.
    Mahjub R; Najafabadi FK; Dehkhodaei N; Kheiripour N; Ahmadabadi AN; Asl SS; Taheri-Azandariani M; Ranjbar A
    Pharm Nanotechnol; 2020; 8(3):239-254. PubMed ID: 32600243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Patent Review on Nanotechnology-Based Nose-to-Brain Drug Delivery.
    Singh R; Brumlik C; Vaidya M; Choudhury A
    Recent Pat Nanotechnol; 2020; 14(3):174-192. PubMed ID: 32384043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microparticles, microcapsules and microspheres: A review of recent developments and prospects for oral delivery of insulin.
    Wong CY; Al-Salami H; Dass CR
    Int J Pharm; 2018 Feb; 537(1-2):223-244. PubMed ID: 29288095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan-Coated Alginate Nanoparticles Enhanced Absorption Profile of Insulin Via Oral Administration.
    Jaafar MHM; Hamid KA
    Curr Drug Deliv; 2019; 16(7):672-686. PubMed ID: 31250754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Insulin: Current Status, Challenges, and Future Perspectives.
    Chellappan DK; Yenese Y; Wei CC; Chellian J; Gupta G
    J Environ Pathol Toxicol Oncol; 2017; 36(4):283-291. PubMed ID: 29431061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-sensitive chitosan-deoxycholic acid/alginate nanoparticles for oral insulin delivery.
    Zhang YW; Tu LL; Tang Z; Wang Q; Zheng GL; Yin LN
    Pharm Dev Technol; 2021 Nov; 26(9):943-952. PubMed ID: 34372745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan and its use in design of insulin delivery system.
    Wong TW
    Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):8-25. PubMed ID: 19149726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the oral delivery of insulin.
    Ramesan RM; Sharma CP
    Recent Pat Drug Deliv Formul; 2014; 8(2):155-9. PubMed ID: 24867419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral insulin-delivery system for diabetes mellitus.
    Kanzarkar M; Pathak PP; Vaidya M; Brumlik C; Choudhury A
    Pharm Pat Anal; 2015 Jan; 4(1):29-36. PubMed ID: 25565158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scalable fabrication of size-controlled chitosan nanoparticles for oral delivery of insulin.
    He Z; Santos JL; Tian H; Huang H; Hu Y; Liu L; Leong KW; Chen Y; Mao HQ
    Biomaterials; 2017 Jun; 130():28-41. PubMed ID: 28359018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.